SAN DIEGO, CA - March 12, 2025 ( NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce.

Trade Fight Widens as Europe and Canada Retaliate Against Trump Tariffs As President Trump’s global tariffs on metals took effect, the European Union and Canada announced billions of dollars in ...

Return of former board member Lip-Bu Tan sends shares in US chip group 11% higher in post-market trading ...

Do you want to know how you can develop new drugs to combat drug-resistant microorganisms? How to find a way to imprint the immune system to increase tolerance? Reducing the side effects of treatment ...